Effects of kidney function, serum albumin and hemoglobin on dementia severity in the oldest old people with newly diagnosed Alzheimer’s disease in a residential aged care facility: a cross-sectional study

Table 1 Baseline demographic and clinical characteristics of patients

Total number of patients	n = 84
Age (years)	86.6 ± 3.9
Men, n (%)	78 (92.9)
Education (> 6 years),n (%)	37 (44.0)
Number of medications, mean (SD)	4.7 ± 3.0
Lifestyle behaviors, n (%)
Tobacco smoking habit	30 (35.7)
Alcohol drinking habit	19 (22.6)
Comorbidities, n (%)
Hypertension	51 (60.7)
Cardiovascular disease	18 (21.4)
Diabetes mellitus	15 (17.9)
Cerebral vascular disease	13 (15.5)
Number of comorbidities, mean (SD)	2.3 ± 1.4
Geriatric assessment, mean (SD)
MMSE	10.1 ± 6.7
CDR	1.6 ± 0.7
ADL	68.8 ± 28.5
GDS	3.2 ± 3.8
Laboratory data, mean (SD)
Creatinine (mg/dL)	1.2 ± 0.4
eGFR (mL/min/1.73m²)	61.7 ± 21.5
Fasting glucose (mg/dL)	95.2 ± 28.0
Triglyceride (mg/dL)	142.1 ± 62.4
Cholesterol (mg/dL)	146.3 ± 50.5
Albumin (g/dL)	4.5 ± 4.8
GPT (U/L)	14.9 ± 7.3
White blood cell (/mm³)	6136.6 ± 2070.4
Hemoglobin (g/dL)	12.7 ± 1.7
Vitamin B12 (pg/mL)	409.9 ± 223.3
TSH (μIU/mL)	1.6 ± 1.3
MDRD eGFR (mL/min/1.73m²),n (%)
eGFR≥60	42 (50.0)
eGFR45–59.99	21 (25.0)
eGFR< 45	21 (25.0)

eGFR Estimated glomerular filtration rate, calculated by MDRD; MMSE Mini-mental state examination; CDR Clinical Dementia Rating Scale; ADL Activities of daily living; GDS Geriatric depression scale; GPT Glutamic pyruvic transaminase; TSH Thyroid-stimulating hormone; number of comorbidities (comorbidities included depression, hypertension, cardiovascular disease, diabetes mellitus, cerebral vascular disease, lung diseases, kidney diseases, liver diseases, gastrointestinal diseases, and genitourinary diseases)

ISSN: 1471-2318